• Marketsetup
  • Blog
    • By Tags
  • News
  • Documentation
    • Jugaad Data
    • Jugaad Trader

Alkem Laboratories Q1 FY26: Unpacking India Pharma's Outperformance & Strategic Bets for Future Growth

Alkem Laboratories’ Q1 FY26 results reveal a pharma giant outperforming in India while …

Aug 21, 2025 13:36

Innova Captab Q1 FY26 Results: Is This Pharma Stock Poised for Explosive Growth?

Innova Captab’s Q1 FY26 earnings reveal robust revenue growth, fueled by a standout …

Aug 18, 2025 13:28

GlaxoSmithKline Pharma's Q1 FY26: Flat Revenue, Explosive Profit Growth. Unpacking Their Strategic Pivot.

Discover how GSK Pharma defied expectations in Q1 FY26, turning flat revenue into a stunning profit …

Aug 18, 2025 13:06

Alembic Pharma Q1 FY26: Decoding Growth, Margins & Future Earnings Potential

Alembic Pharma kicked off FY26 with mixed yet encouraging Q1 results. This analysis delves into the …

Aug 17, 2025 13:48

Zim Laboratories Q1 FY26: Profit Plunge or Hidden Growth Catalyst? Unpacking the Numbers

Zim Laboratories reported a challenging Q1 FY26, with profits plummeting due to geopolitical …

Aug 17, 2025 12:46

Medicamen Biotech's Staggering Q1 Loss: What Drove the Plunge and Can it Recover?

Medicamen Biotech just released its Q1 FY25 results, showing a stark swing from profit to …

Aug 16, 2025 16:26

Gland Pharma's Q1 FY26: Profit Jumps 50% & Cenexi Breaks Even – Is This The Pharma Giant's Resurgence?

Gland Pharma’s Q1 FY26 results show a powerful rebound, with profits soaring by 50% and its …

Aug 15, 2025 13:32

Medicamen Biotech Q1 FY26: Profits Plummet, But One Key Number Soars. What's Driving MBIL's Mixed Fortunes?

Medicamen Biotech’s Q1 FY26 results are in, revealing a complex financial picture. While …

Aug 15, 2025 01:22

Senores Pharmaceuticals Q1FY26: 71% Revenue Surge & The Strategic Moves Fueling Its Super Growth

Senores Pharmaceuticals’ Q1FY26 results are turning heads with impressive growth across key …

Aug 11, 2025 01:27

Cipla's Bommasandra Plant Gets Favorable USFDA Nod! 💊

Cipla’s Bengaluru manufacturing facility received a ‘Voluntary Action Indicated’ …

Aug 5, 2025 09:06

Shilpa Medicare's Bengaluru Unit Gets Positive USFDA Nod, Stock Up 4.8%! 📈

Shilpa Medicare’s Bengaluru Unit VI received a positive USFDA inspection outcome (VAI), …

Jul 16, 2025 11:32
  • About
  • Privacy Policy
  • Contact us